Five minutes with . . . Louis CheslerBMJ 2017; 356 doi: https://doi.org/10.1136/bmj.j1304 (Published 14 March 2017) Cite this as: BMJ 2017;356:j1304
- Anne Gulland
“We commonly come across this problem [inability to get children into drug trials] when a patient relapses with cancer and needs some modern targeted drug. Often the parents are internet savvy and aware that there is a drug trial for adults and will ask for their child to go on it. It generates a lot of frustration and anxiety, and it’s upsetting for paediatricians to have so few choices. …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial